Focal therapy and prostate cancer

UCL researcher Hashim Uddin Ahmed is conducting a series of world-first trials into an alternative form of treatment for prostate cancer. Prostate cancer is the most common cancer affecting men in the UK, with conventional treatment for the disease causing many distressing sid effects. Mr Ahmed is a Medical Research Council Clinical Research Fellow in the UCL Division of Surgery and Interventional Science. Results from the groundbreaking trials he has undertaken have shown that one-third of men with prostate cancer might benefit from high-intensity focused ultrasound (HIFU). The New England Journal of Medicine today published a commentary by Mr Ahmed about his work in this area. Mr Ahmed explains his research below. 'Prostate Cancer affects 500,000 men around the world every year.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience